학술논문

Feasibility, acceptability and safety of personalized adaptive enzalutamide therapy in people with metastatic castrate-resistant prostate cancer (mCRPC): EnzAdapt
Document Type
Journal
Source
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY; JUL 2023, 19 p71-p72, 2p. Supplement: 2
Subject
Language
English
ISSN
17437563